Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature Communications|May 13, 2026
Engineering B cells to express fully customizable antibodies with enhanced Fc functionsChun Huang, Atishay Mathur, Chan-Hua Chang, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Engineering B cells to Express Fully Customizable Antibodies with Enhanced Fc FunctionsChun Huang, Atishay Mathur, Chan-Hua Chang, et al.
Frontiers in Immunology|August 5, 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphomaKate J Dixon, Kristin M Snyder, Melissa Khaw, et al.
The Journal of Infectious Diseases|January 11, 2024
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV InfectionJeffrey S Miller, Joshua Rhein, Zachary B Davis, et al.
Blood|August 2, 2022
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemiaFrank Cichocki, Jodie P Goodridge, Ryan Bjordahl, et al.
Archives of Biochemistry and Biophysics|December 24, 2025
Adrenodoxin alters human cytochrome P450 27A1 structure and reaction efficiency beyond supplying electronsQuoc T Vu, Katherine C May, Leonard B Collins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell TransplantationZachary B Davis, Sarah A Cooley, Frank Cichocki, et al.
Neuro-Oncology|July 11, 2026
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engagerJian-Fang Ning, Zachary B Davis, Qudsia Zeb, et al.
Nature Communications|November 29, 2022
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myelomaFrank Cichocki, Ryan Bjordahl, Jodie P Goodridge, et al.
Science Translational Medicine|November 5, 2020
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapyFrank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, et al.
Pageof 3